Navigation Links
Beckman Coulter Announces First Quarter 2009 Results
Date:4/28/2009

$61.8 (35.9%) Tax Rate (13.2%) 23.4% Diluted Earnings per Share(1) $0.32 $0.63 (49.2%) Adjusted Results Excluding Special Items ---------------------------------------- Revenue Growth- Constant Currency (0.2%) Recurring Revenue Growth- Constant Currency 4.7% Operating Income $66.0 $63.5 4.0% Diluted Earnings per Share pre-APB 14-1 $0.74 $0.68 8.8% Diluted Earnings per Share post-APB 14-1(1) $0.71 $0.65 9.2% See "Non-GAAP Financial Measures," where the impact of certain items on reported results are discussed. 1. Earnings, in both 2008 and 2009, include the incremental interest expense associated with FSP No. APB 14-1 "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)"

Scott Garrett, chairman, president and chief executive officer, said, "Approximately 80% of our revenue is recurring, which continued to grow at 5% on a constant currency basis giving us confidence that we will achieve our full year earnings goals. Within the quarter, an increase in pension expense, legal settlements and a strengthening dollar were offset by effective currency hedging, a favorable product mix and determined expense management. Despite a difficult operating environment which constrained top-line growth, adjusted net earnings per fully diluted share grew over 9%, adjusted EBITDA increased 13% and operating cash flow was $106 million, up $44 million."

Total revenue from Clinical Diagnostics customers decreased 3.7% from prior year quarter, up 1.6% in constant currency. Within Clinical Diagnostics, solid recurring revenue gains were offset by significant decreases in cash instrument
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes
2. Beckman Coulter to Webcast Annual Stockholders Meeting
3. Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation
4. Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
5. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
6. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
7. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Beckman Coulter to Host Annual Business Review
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
11. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... 53rd European Society for Paediatric Endocrinology (ESPE) Meeting  ... science and medical research in the field of growth  ... KGaA, Darmstadt, Germany , today announced ... (GGI) for 2014. The awards were announced during a ...
(Date:9/18/2014)... , Sept. 18, 2014 About POCT ... is performed outside a clinical laboratory. It helps ... administrating appropriate treatments and medication. POCT is gaining ... of lifestyle diseases such as diabetes, heart disease, ... POCT devices are standardized to minimize errors during ...
(Date:9/18/2014)... 18, 2014 ... ) has announced the addition of ... Strategic Business Report" report to ... report analyzes the worldwide markets for ... the following Product Segments: Polymeric Materials, ...
(Date:9/18/2014)... 2014 Research and Markets ... N-acetylcysteine Industry Report 2014" report to their ... Report 2014 is a professional and in-depth study ... industry. The report provides a basic ... and industry chain structure. The N-acetylcysteine market analysis ...
Breaking Biology Technology:EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global N-acetylcysteine Industry Report 2014 2
... Gunther von Hagens, BODY WORLDS 2:,The Original ... the Maryland,Science Center this Saturday, February 2nd. The ... Three Pound Gem, a special feature on,the brain., ... specimens, including,whole bodies, healthy and unhealthy organs, body ...
... Dr. Pollard Brings the Highest Level of Clinical ... Feb. 1 Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical ... patented,immunotherapeutic platform technology, announced that it has appointed,Richard ... Dr. Pollard has been a leader in HIV/AIDS ...
... FOLD ), today announced that John F. Crowley, ... at the Merrill,Lynch Global Pharmaceutical, Biotechnology & Medical Device ... at 11:40 am (Eastern Standard,Time) at the Grand Hyatt ... may be accessed by visiting,Amicus, website at http://www.amicustherapeutics.com ...
Cached Biology Technology:Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3
(Date:9/18/2014)... happy-go-lucky characters, so you might expect that most would ... fact some dogs are distinctly more pessimistic than others, ... "This research is exciting because it measures positive and ... offers researchers and dog owners an insight into the ... Melissa Starling, from the Faculty of Veterinary Science. Her ...
(Date:9/18/2014)... Elsevier, a world-leading provider of scientific, technical ... Australasian Research Management Society (ARMS), recognized the academic ... 5th Scopus Young Researcher of the Year Awards. ... the National Convention Centre and in conjunction with ... guests representing Australia,s and New Zealand,s scientific community. ...
(Date:9/18/2014)... New research has found clownfish larvae can swim up to ... better able to cope with environmental change. , Clownfish spend ... anemone but as babies they must wander the open ocean, ... of Excellence for Coral Reef Studies (Coral CoE) at James ... they go, but now we,ve been given a rare glimpse ...
Breaking Biology News(10 mins):Dogs can be pessimists too 2Dogs can be pessimists too 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Nemo's epic journey to find a new home 2
... structure and operating procedures of a powerful anti-bacterial ... antibiotics. In research published in the ... USA, scientists from Monash University, The Rockefeller University ... bacteriophage lysin, PlyC, kills bacteria that cause infections ...
... to train horses have raged for centuries. Two years ... ban the practice of hyperflexion as a result of a ... the animals unnecessary discomfort. The FEI did make a ... what it termed "low, deep and round" (LDR), which essentially ...
... /PRNewswire-Asia/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: ... developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and ... the Company was recently granted a new patent (Patent ... Extraction Method. The new patent grant followed ...
Cached Biology News:New recruits in the fight against disease 2Bend or stretch? How stressful is hyperflexion of horses' necks? 2China Botanic Receives Patent on its Schisandra Lignin Extraction Method 2China Botanic Receives Patent on its Schisandra Lignin Extraction Method 3
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,518-2) ... assistance. Material: cap polystyrene ...
... This CLS number is a ... match Cornings product number. If showing ... the old Sigma-Aldrich number (Z71,517-4) or ... Material: cap polystyrene (expanded surface, easy ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
Biology Products: